SCHEMBL18124336

SCHEMBL18124336

C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CC=C(OS(=O)(=O)C(F)(F)F)C(C)(C)C5CCC43C)C12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 7/20 0.61
NT5E P21589 4/20 0.61
LMNA P02545 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
PRKCG P05129 2/20 0.57
GLI1 P08151 2/20 0.57
RELA Q04206 1/20 0.57
PTPN1 P18031 2/20 0.56
USP2 O75604 1/20 0.56
HIF1A Q16665 1/20 0.56
AKR1B10 O60218 1/20 0.56
ALB P02768 1/20 0.56
POLB P06746 1/20 0.56
AKR1B1 P15121 1/20 0.56
DPP4 P27487 1/20 0.56
RORC P51449 1/20 0.56
SAE1 Q9UBE0 1/20 0.56
UBA2 Q9UBT2 1/20 0.56
CES2 O00748 2/20 0.54
CES1 P23141 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17162701 1.00 GPBAR1 (0.61) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL9891372 0.95 GPBAR1 (0.55) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL14682826 0.95 GPBAR1 (0.55) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL9888542 0.93 GPBAR1 (0.53) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL9105293 0.93 GPBAR1 (0.53) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL9888468 0.92 GPBAR1 (0.52) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL15185806 0.91 GPBAR1 (0.51) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL15185742 0.89 PTGES (0.52) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL9889521 0.89 GPBAR1 (0.49) GPBAR1NT5ELMNASMN1; SMN2PRKCG
SCHEMBL14666427 0.89 CA9 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576585-B1 MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2016-10-12 EP disclosed